Showing results (91-100 of 102) with videos related to
Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2023
Integrated Genomic and Transcriptomic Analysis Improves Disease Classification and Risk Stratification of MDS with Ring SideroblastsGabriele Todisco, Maria Creignou, Elsa Bernard, et al.Blood Advances|June 10, 2022
Genomic characterization of lymphomas in patients with inborn errors of immunityXiaofei Ye, Paul J Maglione, Claudia Wehr, et al.Iscience|May 31, 2023
ADAR1-mediated RNA editing promotes B cell lymphomagenesisRiccardo Pecori, Weicheng Ren, Mohammad Pirmoradian, et al.Haematologica|April 16, 2017
Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: a study by the Lunenburg Lymphoma Biomarker ConsortiumWendy B C Stevens, Matias Mendeville, Robert Redd, et al.Blood|January 18, 2024
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphomaMohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord, et al.Blood|July 28, 2011
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 casesAnastasia Hadzidimitriou, Andreas Agathangelidis, Nikos Darzentas, et al.Cancer Research|August 24, 2012
Molecular subsets of mantle cell lymphoma defined by the IGHV mutational status and SOX11 expression have distinct biologic and clinical featuresAlba Navarro, Guillem Clot, Cristina Royo, et al.The Journal of Experimental Medicine|May 20, 2015
Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemiaLarry Mansouri, Lesley-Ann Sutton, Viktor Ljungström, et al.Blood Advances|July 11, 2022
Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IVG Tjitske Los-de Vries, Wendy B C Stevens, Erik van Dijk, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2019
Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker ConsortiumAndreas Rosenwald, Susanne Bens, Ranjana Advani, et al.Pageof 11